The strongest PARP inhibitor for breast cancer! Talzenna reduces the risk of deterioration by nearly 50% 20/06/2022 breast cancer BRCA gene
An article will take you to understand the efficacy and side effects of Nirapali and pictures 20/06/2022 other BRCA gene
How to treat brain metastasis of breast cancer? ADC drug Enhertu disease control rate exceeds 90% 20/06/2022 Lung cancer, breast cancer HER2 gene
The new findings offer improved treatment options for early-stage BRCA-mutant breast cancer. 09/06/2022 breast cancer BRCA1 and BRCA2
Hong Kong's first stereo positioning radiation therapy + immunotherapy combination therapy, a new hope for liver cancer patients 09/06/2022 liver cancer FGFR
What is the effect of Abecili/Bomacillin (VERZENIO) in the treatment of HR+/HER2-breast cancer patients? 09/06/2022 breast cancer (HR+)/HER2
Breast cancer cells may change their identity and become more aggressive 09/06/2022 breast cancer CXADR
Triple-negative breast cancer survival significantly improved! Cosela receives FDA Fast Track designation. 08/06/2022 breast cancer G1
An article will take you to understand the efficacy and side effects of Nirapali and pictures 08/06/2022 上皮性卵巢癌 BRCA
Longest survival data for breast cancer! Kisqali (Ribociclib) requires over 4 years of delayed chemotherapy. 08/06/2022 breast cancer HR+/HER2
